Agoracom Blog Home

Posts Tagged ‘small cap stocks’

Empower Clinics $CBDT.ca – #Marijuana Survey Shows #Boomers Embracing #Cannabis & #CBD According to Aging Expert, Lisa Cini $WEED.ca $CGC $ACB $APH $CRON.ca $HEXO.ca $OGI.ca

Posted by AGORACOM-JC at 6:15 PM on Monday, March 16th, 2020

SPONSOR:

Why Empower Clinics

  • A leading owner/operator of physician staffed health and pain management clinics.
  • Patient database of over 165,000 patients 
  • Platform generating $1.4M USD (9 months ending Sept. 30, 2019)
  • Proprietary technology platforms including Electronic Health Records portal and e-Commerce for CBD product distribution
  • Recently launched CBD extraction facility
  • First extraction system capacity = 2,300 Kg per year.
  • CBD based products are poised to be a $20B global industry by 2022
  • Medical cannabis is poised to be a $100B global industry by 2025
  • Company to Create Psilocybin and Psychadelics Division Leveraging Corporate Wellness Clinics and Franchise Clinic Network

Marijuana Survey Shows Boomers Embracing Cannabis & CBD According to Aging Expert, Lisa Cini

COLUMBUS, Ohio -With 9 in 10 Americans favoring legalization of Marijuana for recreation or medicinal purposes and New York weeks away from a decision, aging expert Lisa Cini shares details of marijuana and cannabidiol (CBD) usage among the 11,000+ boomers who responded to her marijuana survey and answered a variety of questions on marijuana consumption, opinion, and usage.

“It’s time to mainstream senior-friendly tools for using marijuana, and consider implications for designing seniors’ living spaces, or help those marijuana-using seniors living in multi-generational homes to partake in designated ways and areas as not to offend family members who don’t use, including children and grandchildren.”Tweet this

“I’m not surprised that 83% of the respondents are using some form of cannabis for recreational and medical reasons. 66% partake daily and believe that marijuana and/or CBD use is an important component of their lives,” says Lisa Cini, senior living expert and author of BOOM: The Baby Boomers Guide to Leveraging Technology, so that you can Preserve Your Independent Lifestyle & Thrive. “Don’t forget that much of the boomer generation grew up smoking weed. Some never stopped, resumed in retirement, or when they were no longer raising children. Because the aging process is unforgiving as it relates to pain, seniors are finding relief from achy bones and joints, arthritis, sleeplessness, and many other ailments, proving that there’s a great deal more to marijuana than just getting high, especially for those battling health and comfort challenges.”

Seniors are using weed in any number of ways, from smoking to baking and preparing full meals with cannabutter for many perceived health benefits including relief from insomnia, anxiety, chronic pain, depression, muscle tension, arthritis, and migraines in addition to getting high.

For those who desire CBD without THC, popular brands like vitafusion™ now offer gummy vitamins with full spectrum hemp extract and natural phytocannabinoids (225mg & 10mg CBD per gummy), Blissful Sleep with 5mg Melatonin (300mg with 10mg CBD per gummy) to induce sleep, and Chillaxed Mood with natural phytocannabinoids & 10mg L-Theanine (300 mg & 10mg CBD per gummy) to promote calm mental alertness, in contrast to the restless energy sometimes produced by caffeine. CBD creams and other skin care products are touted for anti-aging and appeal to boomers. CBD Anti-Aging Cream with Apple Stem Cells, was voted #1 Best Anti-Aging CBD Skin Cream in 2019 and for those with sensitive skin, Abinoid Botanicals Face Serum – Blue Chamomile & Hemp was voted #2 best hemp cream.

“Marijuana and CBD use is a reality that can no longer be ignored, as it’s very much a part of the daily lives of so many,” adds Cini. “It’s time to mainstream senior-friendly tools for using marijuana, and consider implications for designing seniors’ living spaces, or help those marijuana-using seniors living in multi-generational homes to partake in designated ways and areas as not to offend family members who don’t use, including children and grandchildren.”

Lisa Cini is an award-winning senior living designer, President / CEO, Mosaic Design Studio and author of BOOM: The Baby Boomers Guide to Leveraging Technology, so that you can Preserve Your Independent Lifestyle & Thrive, The Future is Here: Senior Living Re-imagined, and Hive, which describes her family’s four generations living under the same roof in her own home. Go to Lisamcini.com to sign up for her blog. If you want to find the best tech products that help seniors Embrace Aging and Live Independently, visit BestLivingTech.com.

Source: https://www.businesswire.com/news/home/20200309005150/en/Marijuana-Survey-Shows-Boomers-Embracing-Cannabis-CBD

Can #coronavirus do for #edtech what demonetisation did for digital payments in India? – SPONSOR: BetterU Education Corp. $BTRU.ca $ARCL $CPLA $BPI $FC.ca

Posted by AGORACOM-JC at 4:43 PM on Monday, March 16th, 2020
SPONSOR:  BetterU Education Corp. aims to provide access to quality education from around the world. The company plans to bridge the prevailing gap in the education and job industry and enhance the lives of its prospective learners by developing an integrated ecosystem. Click here for more information.

Can coronavirus do for edtech what demonetisation did for digital payments in India?

  • The Covid-19 pandemic has forced several schools and colleges across India to temporarily close. In Delhi alone, over two million kids are being forced to stay at home with primary schools shut until March 31.
  • With fresh cases being reported each day, there are expectations that more schools and colleges will be closed in the coming weeks.

By Ananya Bhattacharya

On Nov. 8, 2016, digital payments companies became mainstream in India overnight after the government suddenly decided to demonetise two high-value currency notes. Now, education technology (edtech) firms are hoping for an encore in the wake of the coronavirus outbreak.

The Covid-19 pandemic has forced several schools and colleges across India to temporarily close. In Delhi alone, over two million kids are being forced to stay at home with primary schools shut until March 31. With fresh cases being reported each day, there are expectations that more schools and colleges will be closed in the coming weeks.

Edtech companies are jumping to make the most of the situation, offering free access to their courses during a time that typically flags off the exam season.

But overnight success might be hard to come for these platforms, experts said.

“While a smartphone is good enough for browsing, social media, and so on, for studies, assignments, and projects, it doesn’t suffice,” Prateek Shukla, CEO & co-founder Bengaluru-based coding bootcamp Masai School, told Quartz. “A stable internet and electricity connection is the biggest challenge.” Power outages are still very frequent across most Indian cities, especially in smaller towns.

And that is just one of the many hurdles. Companies, though, are going all out to make hay.

Wooing India

On March 11, Bengaluru-based Byju’s, the world’s biggest edtech firm, said it was making all its learning programmes for students in classes 1 through 12 free until April-end. Soon after, rival Toppr offered free access to its live and video classes for school kids until March 31, and Unacademy announced 20,000 free live classes for candidates looking to prep for entrance exams for union public service commission, banking, railways, and more.

“We want learners to utilise this time…We will support the education system in every way possible to weather the storm,” said Gaurav Munjal, co-founder and CEO of Unacademy. Toppr said it will consider extending the free access for students if schools don’t reopen after March.

Edtech is already well equipped to handle a possible surge in demand, said Akash Singhal, founder & CEO of edtech startup Illumnus. Teachers producing online lessons have already been working remotely, so there is no additional cost in producing lessons.

The initiatives are already bringing in gains.

Noida-based Gradeup has seen a 25% uptick in daily enrolments since it doubled the number of free video on its platform in light of the coronavirus outbreak.

Source: https://qz.com/india/1817115/byjus-toppr-unacademy-ready-for-coronavirus-pandemic/

Empower Clinics $CBDT.ca – #Cannabis Won’t Cure #Coronavirus, but It Can Help Ease Certain Flu Symptoms $WEED.ca $CGC $ACB $APH $CRON.ca $HEXO.ca $OGI.ca

Posted by AGORACOM-JC at 5:00 PM on Friday, March 13th, 2020

SPONSOR:

Why Empower Clinics

  • A leading owner/operator of physician staffed health and pain management clinics.
  • Patient database of over 165,000 patients 
  • Platform generating $1.4M USD (9 months ending Sept. 30, 2019)
  • Proprietary technology platforms including Electronic Health Records portal and e-Commerce for CBD product distribution
  • Recently launched CBD extraction facility
  • First extraction system capacity = 2,300 Kg per year.
  • CBD based products are poised to be a $20B global industry by 2022
  • Medical cannabis is poised to be a $100B global industry by 2025
  • Company to Create Psilocybin and Psychadelics Division Leveraging Corporate Wellness Clinics and Franchise Clinic Network

Cannabis Won’t Cure Coronavirus, but It Can Help Ease Certain Flu Symptoms

By Brianna Wheeler |

During a normal flu season, frequent weed smokers know the drill.

Pay closer attention to everyone’s cough patterns during a smoke sesh. Stop accepting mouth-wet blunts from strangers. And if you think you’re coming down with something, wave a lighter under the mouthpiece before passing the pipe.

This year, obviously, things are a bit more serious. We’re dealing with multiple citywide quarantines, global economic disruption, and a pandemic being compared to the damn Spanish flu. It’s enough to make self-respecting cannabis enthusiasts re-evaluate their medicine cabinet and diversify their stash box.

Obviously, there’s no dependable research on CBD’s or THC’s effect on COVID-19. But we do know a few things about cannabis and general wellness. Down the rabbit hole of alternative cannabinoids and non-psychoactive cannabis, there is a wealth of potential medicinal benefits both preventative and curative.

At least when it comes to the regular flu, CBD has been found to help support immune systems, ease symptoms, and replace over-the-counter pain relievers, sleep aids, and medicated salves currently taking up space in our medicine cabinet. But not just any CBD will do, and CBD alone won’t do it all.

Obviously, the best course of action right now is to keep vigorously washing your hands, mind your coughs, avoid large crowds, and be a bit more stingy with your pipes and joints. But if you find yourself slipping under the weather, for whatever reason, here are a few things to know about how cannabis might help ease symptoms.

CBD for Immune System Support

Tons more research is required to accurately map the relationship between the immune and endocannabinoid systems, but it’s well established that CBD helps reduce self-harming autoimmune and inflammatory responses. “CBD has been found to act as an immune system modulator,” says Anna Symonds, director of East Fork Cultivars’ CBD Certified program. “This means that it’s like a thermostat—it can turn the level of activity down or up, depending on the body’s needs.”

Source: https://www.wweek.com/potlander/2020/03/10/cannabis-wont-cure-coronavirus-but-it-can-help-ease-certain-flu-symptoms/

#Coronavirus Scare Gives #Telehealth an Opening to Redefine Healthcare #Mhealth SPONSOR: CardioComm Solutions $EKG.ca – $ATE.ca $TLT.ca $OGI.ca $ACST.ca $IPA.ca

Posted by AGORACOM-JC at 6:12 PM on Thursday, March 12th, 2020

SPONSOR: CardioComm Solutions (EKG: TSX-V) – The heartbeat of cardiovascular medicine and telemedicine. Patented systems enable medical professionals, patients, and other healthcare professionals, clinics, hospitals and call centres to access and manage patient information in a secure and reliable environment.

Coronavirus Scare Gives Telehealth an Opening to Redefine Healthcare

With the coronavirus threatening to become a pandemic, health systems and telehealth vendors see this as an opportunity to bring connected health to the forefront – and reshape the future of healthcare.

By Eric Wicklund

March 05, 2020 – As Congress votes on a funding package that includes Medicare waivers for some telehealth services and the Health Information and Management Systems Society (HIMSS) cancels its conference in Florida, healthcare providers across the country are looking at how connected care programs can be used to handle the coronavirus – also called COVID-19 – threat.

Most see the exercise as an extension of their preparations for flu season. Some see this as an opportunity to lobby for telehealth adoption across the board, saying a possible epidemic offers ample evidence of the value of telehealth and mHealth.

Defining Telehealth’s Value in a Changing Landscape

“COVID-19 is different because we do not know all the factors surrounding transmission and its effects on patients,” Jason Hallock, Chief Medical Officer for SOC Telemed, points out. â€œBecause coronavirus is new and there have been a significant number of deaths, the uncertainty surrounding that is scaring both patients and the general public. Our healthcare workers do not have all the answers yet. Telehealth providers are challenged to make recommendations when there are still many unknowns. Telemedicine can be useful to evaluate and reassure patients in alternative settings, and also can be used to help patients decide who needs to be seen in the hospital or an alternative setting like an urgent care.”

Hallock says telehealth can help by enabling healthcare providers to treat isolated patients, thus preventing the spread of what has so far been an extremely contagious virus.

In a Q&A with mHealthIntelligence, Peter Antall, MD, President and Chief Medical Officer for American Well, offered an in-depth take on how telehealth might be used.

READ MORE: Scripps Researchers Use mHealth Wearables to Track Flu Outbreaks

Q. Telehealth has long been seen as an ideal means of expediting care during flu outbreaks. How is the coronavirus scare different? Does this pose any unique challenges that telehealth can address?

A. The novel coronavirus, or COVID-19, is similar to influenza in how it is transmitted (airborne), how symptoms manifest themselves, and the fear it stirs among those individuals at risk. When evaluating patients through telehealth, we use similar methodology as that used for influenza, except that the current Centers for Disease Control and Prevention (CDC) recommendations call for risk stratification based on known exposure or travel to endemic areas and referral for testing for those at high risk or those who are sick enough to need hospital care. Also, unlike with influenza, there are no current specific treatments, like antivirals, for the coronavirus at this time. 

If local person-to-person spread expands to wide community spread, we expect care will need to evolve to a method that is quite similar to how we treat influenza today. Under those circumstances, we will likely begin diagnosing coronavirus-like illness (CLI) on a clinical basis, without testing. We would likely then only be expected to refer inpatients with CLI who need hospital care clinically, while those with milder symptoms will likely be treated and monitored at home so as to limit the spread of this disease and not overwhelm our healthcare facilities.

In this way, telehealth is an ideal venue for an outbreak like this. We can increase access to care. We can offer care that is commensurate with the acuity and nature of the symptoms and make referrals as needed. This helps with infection prevention and control and also allows patients to receive their care in the home without exposing themselves to further illness.

One other notable point is the potential for telehealth to help in providing routine care for other conditions and offset coronavirus fears in the . Patients have other healthcare needs unrelated to coronavirus, but many are afraid to go to healthcare settings for fear of catching disease. This has begun to result in a migration of patients to telehealth. For example, on February 25, we saw telehealth urgent care patient volume that was 11 percent higher than expected. Many patients are now sharing anecdotes indicating they were afraid to sit in a waiting room, so they used telehealth instead.

READ MORE: Using Telehealth Technology for Care Coordination During a Disaster

Q. Are there new tools or technologies available that can be useful in dealing with the coronavirus?

A. Telehealth itself is a tool in this fight. Keep in mind that there are many varieties of telehealth. It can be used to connect a doctor or other provider with a patient in the home via smartphones or tablets. It can also be used for provider (specialist)-to-provider consultations in remote areas, for example. Telehealth carts also exist in healthcare settings and can be used not only to import care, but also to limit healthcare workers’ exposure to the virus by using a cart in the isolation room.  We see patients primarily through live video interactions, but we also can fall back to informed telephone calls, synchronous chatting for therapy and asynchronous secure messaging for ongoing communications.

The use of symptom trackers and chatbots is another promising area for coronavirus response. These technologies allow algorithms to be created and adjusted as more is learned about the coronavirus. These bots interact with patients and can perform assessments, triage and ongoing support. The bots can even escalate an interaction to a telehealth encounter or refer the patient for in-person care.

Finally, home monitoring and medical tricorders are another promising approach to care. Traditional remote patient monitoring has established value for managing certain chronic conditions, but the next wave of home monitoring includes consumer devices like smartwatches (like the Apple Heart Study), home TVs, and home medical tricorders like Tytocare that can perform a remote examination. These tools aid clinicians and patients and provide more robust health data conveniently from the home setting. Providers can also use the data generated to better care for the patient or regularly monitor certain conditions.

Q. What must care providers know about telehealth before using it to deal with the coronavirus?

READ MORE: HHS Is Looking For mHealth Devices That Can Diagnose Influenza

A. Providers must know and understand their role in this or any other healthcare crisis. They should be well informed and trained to follow current CDC or World Health Organization guidelines. They should also understand that telehealth is a powerful tool for helping fight this outbreak. And they should know that telehealth is a safe way to treat and/or triage these patients. Whether the provider is a primary telehealth provider or is not using telehealth today, there is a real opportunity to participate and play a role in the response. 

Providers who have a brick-and-mortar practice should be encouraged to use telehealth as a triage tool. Providers also need to understand that during this time, patients with other non-respiratory conditions also need care. These patients should be afforded a safe way to access care without risk of infection. Telehealth is also a tool to aid in this process, as some patients are fearful of going to healthcare facilities right now. The office-based provider can likewise process other patients by practicing this way.

Q. What are the barriers or challenges associated with using telehealth to deal with the coronavirus scare?

A. Telehealth visits are typically sufficient to complete a robust initial assessment. This allow the provider to assign a risk category, make other diagnoses, or deem the patient as “worried well.” Some patients may require additional care, as most telehealth in the home lacks certain medical peripherals that might be needed. Other reasons for referral would include a high-risk patient who needs to be tested or a patient who requires escalation of care due to the severity of their illness. Telehealth visits are generally sufficient for screening patients, assigning a risk category, answering questions and recommending the next steps a patient should take.

The barriers to telehealth—such as instances when the patient and provider do not yet have a relationship—are easily overcome providers receive similar training around the use of telehealth and as longitudinal patient records become more available to guide care. Occasionally the lack of medical peripherals or the inability to touch the patient during an exam is a barrier, as some patients need hands on care (e.g., IV, procedures). We have policies that mitigate these problems in most cases. However, on occasion, a telehealth patient must be referred for in-person evaluation.

Q. Is there anything that the CDC or any other government agency can do to support telehealth adoption to deal with the coronavirus? 

A. It is useful for the CDC (and the WHO) to highlight the important role of telehealth in this outbreak because it certifies our role within the broader medical community and raises awareness about this tool.

It would be helpful if the CDC were to make specific recommendations to telehealth providers that relate to telehealth evaluation of the coronavirus and associated referrals, coding and monitoring. It would also be helpful if the CDC were to play a role in advocacy efforts focused on government reimbursement, particularly in this emergency situation. Efforts to increase consumer awareness about telehealth as a safe option for care also could prove essential. When this outbreak settles down, we would encourage the CDC and HHS to collaborate around coronavirus standards of care and preparedness so that patients can expect telehealth providers to be ideally prepared and well-coordinated for the next outbreak and so that we can offer high-quality care in this manner to all Americans.

We also believe that our public health system would benefit greatly from owning its own telehealth network infrastructure. This would allow the CDC to better scale up, solve for geography and improve surveillance. It would even allow its public health workers to use technology to monitor patients under quarantine in the home, saving themselves travel and limiting healthcare workers’ exposure.

Q.  What more can be done with telehealth in the future to plan for these types of outbreaks, or to perhaps address them before they become serious?

A. Much needs to be done throughout our country to better prepare. We need permanent leaders placed at the U.S. Department of Health and Human Services, the National Institutes for Health, the US Department of Homeland Security and other key areas, and we need to reinstate a pandemic-preparedness role at the National Security Council. We need to fund international efforts to improve screening and research for emerging diseases, and we need surveillance programs and good international coordination. We need to fund (not decrease funding) for our frontline groups, like the CDC, HHS and local public health services. These are our fighters, and we need them ready and funded properly as an outbreak like this is a national security issue. We need stockpiles of materials. Finally, we should be partnering with the pharmaceutical industry on affordable medications and vaccine research.

Our national telehealth operation today acts like an emergency alert system. We see cases or potential cases before they are reported. At American Well, our influenza activity indicator map is more accurate and more timely than that of the CDC. We already play a meaningful role in many disease states, including outbreaks. There are still many adoption and awareness challenges that exist when it comes to telehealth. Hopefully this unfortunate event will help consumers, providers and others start to more clearly see how they can and should use telehealth for future healthcare needs.

Another barrier that we continue to work on is that of reimbursement. Telehealth is a cost-effective way of receiving care, but it is still not always a covered benefit by insurance. Most commercial plans are reimbursing and there is increasing adoption in Medicare Advantage and Medicaid managed care. But there are still gaps, including a big gap in fee-for-service coverage for Medicare coverage in the home. Efforts at reform are underway (see the CONNECT Act), but more work needs to be done so that all Americans can take advantage of this amazing service.

Additionally, with coordination being so important during outbreaks like this, the simple step of integrating telehealth with other health information systems, such as EHRs or clinical-decision support, can make care more seamless and foster better care coordination. This would speed up access to critical care. Case in point: Consider a scenario where a patient consults with a physician over a telehealth network and displays symptoms of COVID-19 while presenting one or more correlating risk factors. The physician could easily document the experience, dispatch an alert to a local ED, and ensure precautions are taken by medical staff to usher this patient into a contained room or unit to begin testing and treatment. We’re working to ensure this type of communication is happening at all levels, but there’s still much room for improvement on this front. 

Health System Execs Respond to the Threat

In an op-ed prepared for the Alliance for Connected Care, Todd J. Vento, MD, MPH, Intermountain Healthcare’s Medical Director of Infectious Diseases Telehealth Service; Ethan Booker, MD, Medical Director of MedStar’s Telehealth Innovation Center; and Lawrence “Rusty” Hofmann, MD, Stanford Health’s Medical Director of Digital Health, made their pitch for telehealth:

“Telehealth, which has proven to be a very useful tool in addressing patient needs during flu season, will improve our collective ability to address COVID-19 if it hits on a larger scale. Telehealth offers several advantages over in-person care in the event of a pandemic.

One key advantage of telehealth is speed,” the three wrote. “Patients can access clinicians 24/7 without an appointment or physical trip to the doctor. Using telehealth, our providers in the Stanford Primary Care team, MedStar Health and Intermountain Healthcare have been actively evaluating and treating patients with influenza.  Current providers at Stanford Health estimate that almost 50% of patients are getting oseltamivir (Tamiflu).  Because there is no current, specific medication for Coronavirus, we must be able to advise patients of reasonable self-directed treatment and surveillance to keep them home. 

Keeping patients at home is a significant advantage of telehealth. In-home video visits limit community exposure by allowing patients to avoid contact with other patients in waiting rooms and direct contact with providers during the exam.  Our health systems have providers who are equipped to work from their own homes, significantly increasing the safety of providers and bolstering the workforce to respond to crisis.  Workforce readiness in a crisis that may include such dramatic measures as school and day care closures is a significant concern for health systems which may be strained to respond.  Health systems are also using telehealth to continue surveillance of patients already identified as at risk while keeping them at home.

Next, telehealth ensures that treatment in brick-and-mortar settings is reserved for high-need patients.  Moreover, with patients being seen in their own homes, providers and health systems will be able to triage and screen exponentially more patients with telehealth vs. an in-person visit.

Finally, telehealth allows patients who do not have access to infectious diseases (ID) specialists to access this specialized care from the small number of experts across the country. When Intermountain first offered ID telehealth consultation to rural systems throughout the west, one provider fielded 1,000 consultation requests in the first fifteen months. To date, the service has provided telehealth care to over 4,700 patients, 50 percent of whom are over 65 years old.

Each of these advantages illustrate how telehealth can thwart the spread of COVID-19 and stop it from overwhelming our already stretched medical system.”

The three health executive also urged lawmakers to take action to reduce barriers to telehealth that have kept adoption low:

“Congress must act to ensure that seniors – a particularly vulnerable population generally and for this virus in particular – are able to receive necessary triage and care through telehealth. 

Today, there are restrictions in Medicare that prevent providers outside of very rural areas from being paid for care provided through telehealth. As a result, many providers do not offer telehealth services to seniors. The lack of reimbursement creates a perverse incentive of encouraging patients to come for in-person care, which will only overwhelm our health system as well as augment the virus’s spread.

Congress must give the Secretary of Health and Human Services the ability to waive these restrictions in times of public health emergencies. As part of the bipartisan, bicameral CONNECT for Health Act, telehealth champions in Congress foresaw this need and drafted a provision that would give the Secretary the ability to waive telehealth restrictions just as he/she would waive Conditions of Participation, Stark Laws licensure, or other requirements when public health emergencies are declared.”

Source: https://mhealthintelligence.com/news/coronavirus-scare-gives-telehealth-an-opening-to-redefine-healthcare

#Edtech firms offer free access to colleges that is impacted by #Coronavirus – SPONSOR: BetterU Education Corp. $BTRU.ca $ARCL $CPLA $BPI $FC.ca

Posted by AGORACOM-JC at 5:12 PM on Thursday, March 12th, 2020
SPONSOR:  BetterU Education Corp. aims to provide access to quality education from around the world. The company plans to bridge the prevailing gap in the education and job industry and enhance the lives of its prospective learners by developing an integrated ecosystem. Click here for more information.

Edtech firms offer free access to colleges that is impacted by Coronavirus

Beginning Thursday, online learning giant Coursera said it is going to provide every impacted university in the world free access to its course catalogue through ‘Coursera for Campus’ until July 31

  • Beginning Thursday, online learning giant Coursera said it is going to provide every impacted university in the world free access to its course catalogue through ‘Coursera for Campus’ until July 31.

By: Neha Alawadhi & Samreen Ahmad

Online education companies in India and globally are offering their paid programmmes to students — whether in school or pursuing higher education — free of cost because of the COVID-19 pandemic.

Beginning Thursday, online learning giant Coursera said it is going to provide every impacted university in the world free access to its course catalogue through ‘Coursera for Campus’ until July 31.

“We’re going to make ‘Coursera for Campus’ offering freely available to any college or university in the world that is impacted by coronavirus, in the hope that they can rapidly allow students to start learning and ensure we have minimal impact from coronavirus on the student community,” said Leah Belsky, chief enterprise officer and senior vice-president, Coursera.

Coursera, founded by Stanford Professors Andrew Ng and Daphne Koller, has 48 million registered learners worldwide and offers courses, specialisations, degrees, and certificate programmes online.

The ‘Coursera for Campus’ offers job-relevant online education to students, alumni, faculty, and employees of firms like Mindtree, Tata Communications, Axis Bank, Infosys, Airtel, and Manipal Group.

Indian universities can continue teaching their students online without creating new infrastructure. Coursera’s existing ‘Coursera for Campus’ partners include Manipal Academy of Higher Education, UPES, Shiv Nadar University, KL University, NMIMS, and Pearl Academy.

In India, it has 5 million registered learners, and is adding over 100,000 learners per month.

Universities can sign up to provide their enrolled students with access to more than 3,800 courses and 400 specialisations from Coursera’s top university and industry partners.

Similarly, Indian education technology firms are also offering free classes and course material for students impacted by the novel coronavirus. On Wednesday, the World Health Organization declared COVID-19 a global pandemic.

Edtech firm Byju’s also said it will provide free access to its complete app to school students till the end of April.

Some Indian states like Kerala, Karnataka and New Delhi have already announced the closure of schools.

A UNESCO report states that the education of over 290 million students across 13 countries will be interrupted because of the COVID-19 pandemic.

Another edtech platform Unacademy said it will conduct close to 20,000 free live classes on its platform, across exam categories like UPSC, banking, railways and so on.

Unacademy claims it has 10,000 educators, 13 million learners, and subscriptions for over 30 exam categories.

Educational Initiatives, a 20-year old edtech company based out of Bengaluru is also offering 60 days free access of Mindspark to all students, so that the school closure due to COVID-19 does not impact their learning.

Mindspark is an artificial intelligence-powered specialised mathematics programme developed for children’s learning.

Similarly, edtech firm Toppr is going to provide free live classes to students in classes 5 to 12.

While it is yet to be seen how effective these measures will be, Coursera’s Belsky said the US education system invested in digitising after events like Hurricane Katrina, which forced school and college students to miss studies for months.

According to some estimates, in New Orleans alone, 110 of the 126 public schools were completely destroyed and students had to be moved to neighbouring states to complete their education.

Source: https://www.business-standard.com/article/education/edtech-firms-offer-free-access-to-colleges-that-is-impacted-by-coronavirus-120031201574_1.html

Digital Learning #Edtech: Can it Solve the Access to Education Problem for Indian Students? – SPONSOR: BetterU Education Corp. $BTRU.ca $ARCL $CPLA $BPI $FC.ca

Posted by AGORACOM-JC at 4:20 PM on Wednesday, March 11th, 2020
SPONSOR:  BetterU Education Corp. aims to provide access to quality education from around the world. The company plans to bridge the prevailing gap in the education and job industry and enhance the lives of its prospective learners by developing an integrated ecosystem. Click here for more information.

Digital Learning: Can it Solve the Access to Education Problem for Indian Students?

  • India is home to the largest youth population in the world.
  • As per recent government statistics, we have an estimated 430 million people under the age of 18.

Author: DQINDIA Online

Digital learning can help tackle existing problems in the education sector such as shortage of skilled teachers, lack of adequate teaching materials and so on.

India is home to the largest youth population in the world. As per recent government statistics, we have an estimated 430 million people under the age of 18. These young minds hold immense potential to build a strong future for themselves and the country. A potential that is often held to ransom by an education system marred by outmoded methods of teaching, disproportionate student to teacher ratio, a shortage of skilled teachers and lack of adequate teaching materials.

At a time when technology is transforming every other aspect of our existence, it is only natural that we turn to tech tools to disrupt the way we learn. A lack of access and resources emerges as a constant stumbling block in our youth’s pursuit of education – a problem that can be tackled by modernising the education system through digital learning. Here’s how:

Education beyond Boundaries

Digital content and e-learning can bring entire teaching modules to your doorstep through smart devices, making it possible for students to continue working toward completing their education even if they jump off the path of traditional learning. With a boom in cheaper data and devices, this mode of learning proves especially effective in pursuit of higher education or career-oriented skills. Access to online learning opportunities through remote classes, webinars and online academies can accord equal learning opportunities to students in Tier II and III cities as well as rural areas where skilled educators in one’s desired field of study may not be available.

Personalised Learning

The advent of deep data analytics, Artificial Intelligence and Machine Learning, personalised learning has become a tangible reality. These tech tools allow enable an identification of student goals – whether it is securing merit, landing jobs or simply amassing knowledge – and create educational content to suit these goals. This promotes a truly personalised approach toward learning. With the inclusion of edtech networks and multimedia in education, learning and teaching methods have evolved greatly in their methodology, style and content.

Learning on the Go

Gadgets are an integral part of the youth’s lifestyle today. From shopping to entertainment and social interactions, they seek everything on their finger tips and on the go. Their approach toward education and learning is no exception to this tendency. Digital learning allows them to consume educational content in a format they’re more comfortable in and at a place and setting of their choosing.

Affordability

The cost of higher education in India is steep. By comparison, specialised online course are far more affordable. If you factor in the costs of moving to and living in a big city for students from Tier II and III cities, small towns and rural areas, professional online courses don’t cost a fraction of brick-and-mortar set ups. It is for this reason that India is fast emerging as the second biggest market for MOOCs or open online courses, after the US. This new educational revolution presents great opportunity to help the youth access high-quality education and training, at affordable price points, from the comfort of their homes.

Job Readiness

The higher education in India essentially revolves around securing a stable – ideally, well-paying – job. With easy access to e-learning platforms and digital content, students can access the right kind of content in a format fit for their preferred mode of consumption and be better equipped to meet this goal. For instance, the same curriculum can be easily tweaked to suit academic and competitive purposes in a cost-effective manner in the e-book format.

Future-Ready Education

The world around us is changing at a lightning fast pace, thanks to the constant eruptions of the technology front. Sadly, most of the traditional forums of learning – be it schools, colleges or universities – find themselves lagging behind when it comes to tailoring the course content as per the changing demands of the times we live in. Besides, overhauling entire course curriculums can often a slow, time-consuming process. In such a scenario, professionally tailored online courses can be a bankable alternative in amassing skills training that contributes to employability and is in line with the learners’ interests.

It is undisputable that the future of education will be defined by digital content and learning. Students in India can ride this wave to tide over the inherent flaws in our education system and set themselves up for success in their chosen profession.

Source: https://www.dqindia.com/digital-learning-can-solve-access-education-problem-indian-students/

Healthcare IT #Mhealth Market Worth $511.06 Billion by 2027 SPONSOR: CardioComm Solutions $EKG.ca – $ATE.ca $TLT.ca $OGI.ca $ACST.ca $IPA.ca

Posted by AGORACOM-JC at 1:15 PM on Monday, March 9th, 2020

SPONSOR: CardioComm Solutions (EKG: TSX-V) – The heartbeat of cardiovascular medicine and telemedicine. Patented systems enable medical professionals, patients, and other healthcare professionals, clinics, hospitals and call centres to access and manage patient information in a secure and reliable environment.

Healthcare IT Market Worth $511.06 Billion by 2027

  • Healthcare IT market is expected to grow at a CAGR of 13.8% from 2019 to reach $511.06 billion by 2027.

London, March 06, 2020 – According to a new market research report “Healthcare IT Market by Product (EMR, mHealth, PHM, RIS, PACS, RCM, Healthcare Analytics, Telehealth, SCM, HIE), Component (Software, Service), Delivery Mode (Web, Cloud) and End User (Hospital, Payer, Pharmacy, Ambulatory, Homecare)- Global Forecast to 2027”, published by Meticulous Research®, the healthcare IT market is expected to grow at a CAGR of 13.8% from 2019 to reach $511.06 billion by 2027.

Health Information Technology (Healthcare IT) is a broad term that defines the technology and infrastructure utilized to record, analyze, and share patient health data in healthcare organizations. The aim of Healthcare IT solutions is to offer better care for patients and help accomplish health equity. It also endorses recording of patient data to improve healthcare delivery and allow for analysis of information for both healthcare practitioners and ministry of health/government agencies.

With increasing pressure to curtail healthcare cost and improve healthcare quality, investments in healthcare IT are gaining traction and are largely driven by the need for savings, economies of scale, and improving cash flow. According to a survey performed by Octopus group, more than 100 global institutional investors have planned to increase their investment in healthcare infrastructure, including health IT, by $200 billion over the next five years. By adopting various healthcare IT solutions such as EHR, PACS, and CPOE among others, healthcare organizations have reduced the operational cost and improved savings along with better patient care. For instance, with increasing adoption of Cerner Dynamic Documentation platform, Northern Light Health (U.S.) saved an estimated $1.3 million annually, by increasing provider efficiency, improving satisfaction with their electronic health record, and streamlining the discharge process. Similarly, by adopting Cerner ITWorks, University of Missouri Health Care (U.S.) reduced the organization’s IV obsolescence rate by more than 43% over three months. In addition, the university also adopted Cerner’s revenue cycle management solutions in 2018.

The healthcare IT solutions market study presents historical market data in terms of value (2017, and 2018), estimated current data (2019), and forecasts for 2027 – by product, component, delivery mode, end-user, and geography. The study also evaluates industry competitors and analyzes their market share at the global and regional level.

Based on product type, the healthcare providers solutions segment accounted for the largest share of the healthcare IT market and is slated to grow faster during the forecast period. The large share of this segment is primarily attributed to the factors such as growing focus on patient safety & care, increasing demand for integrated healthcare solutions, rising investments in development of healthcare infrastructure in emerging countries, increasing number of government initiatives & regulatory mandates on implementing eHealth solutions, increasing demand for quality healthcare, and rising awareness about electronic health records (EHRs). In addition, growing geriatric population & related ailments and patient workload on healthcare systems across the globe are also driving adoption of digitization solutions among healthcare providers.

Based on component type, the services segment held the largest share of the overall healthcare IT market. The largest share of this segment is mainly attributed to the increasing need to reduce healthcare costs, shift towards cloud-based services, rising adoption of digital solutions across healthcare organizations, and growing need to reduce administrative overheads of the healthcare industry.

Based on delivery mode, the overall healthcare IT market is segmented into web/cloud based and on-premises. Web & cloud-based solutions accounted for the largest share of the overall healthcare IT solutions market owing to its benefits such as on lower upfront cost, on-demand self-serving deployment model, excessive storage flexibility, and greater security.

Based on the end user, healthcare providers held the largest share of the overall healthcare IT market and is projected to grow at a fastest CAGR during the forecast period. The largest share of this segment is mainly attributed to rising patient volume, growing awareness about electronic health records (EHRs), growing healthcare spending by the countries across globe, and increasing adoption of healthcare IT solutions by healthcare providers.

The report also includes extensive assessment of the product portfolio, geographic analysis, and key strategic developments adopted by leading market participants in the industry over the past 4 years (2016–2019). The healthcare IT solutions market has witnessed number of new product launches, agreements, partnerships & collaborations, expansions, and acquisitions in the recent years. For instance, in October 2019, Cerner collaborated with ResMed (U.S.) to help providers make more informed treatment decisions, control costs, and deliver seamless care across health systems. Similarly, in July 2019, McKesson opened its new distribution center in Puyallup, Washington, U.S. to serve hospitals, health systems, community pharmacies, and national retail pharmacies across the state of Washington.

The key players operating in the global healthcare IT market are McKesson Corporation (U.S.), Optum Health (U.S.), International Business Machine Corporation (IBM) (U.S.), Allscripts Healthcare Solutions, Inc. (U.S.), athenahealth, Inc. (U.S.), Epic Systems Corporation (U.S.), Dell Technologies Inc. (U.S.), GE Healthcare (U.S.), Cerner Corporation (U.S.), Oracle Corporation (U.S.), Cognizant Technology Solutions Corporation (U.S.), Nuance Communications, Inc. (U.S.), eClinicalWorks (U.S.) NextGen Healthcare, Inc. (U.S.), Computer Programs and Systems, Inc. (CPSI) (U.S.), Conifer Health Solutions, LLC. (U.S.), 3M Company (U.S.), Koninklijke Philips N.V. (The Netherlands), and Infor, Inc. (U.S.) among others.

Source: https://www.globenewswire.com/news-release/2020/03/06/1996384/0/en/Healthcare-IT-Market-Worth-511-06-Billion-by-2027-Exclusive-Report-by-Meticulous-Research.html

DEA Proposes New #Mhealth Rule for Substance Abuse Treatment SPONSOR: CardioComm Solutions $EKG.ca – $ATE.ca $TLT.ca $OGI.ca $ACST.ca $IPA.ca

Posted by AGORACOM-JC at 12:14 PM on Thursday, March 5th, 2020

SPONSOR: CardioComm Solutions (EKG: TSX-V) – The heartbeat of cardiovascular medicine and telemedicine. Patented systems enable medical professionals, patients, and other healthcare professionals, clinics, hospitals and call centres to access and manage patient information in a secure and reliable environment.

DEA Proposes New Mhealth Rule for Substance Abuse Treatment

A proposed rule change would allow providers to use mHealth tools more freely in substance abuse treatment programs, but it isn’t the rule that telehealth advocates have been anticipating.

By Eric Wicklund

March 04, 2020 – Federal officials have proposed easing restrictions on the use of mHealth in substance abuse programs – but the changes aren’t what everyone has been expecting.

Under a notice of proposed rulemaking published last month in the Federal Register, the US Drug Enforcement Agency would allow registered narcotic treatment programs (NTPs) using “mobile components” to consider those connected health elements as a coincident activity.

“The NTP registrants that operate or wish to operate mobile components (in the state that the registrant is registered in) to dispense narcotic drugs in schedules II-V at a remote location for the purpose of maintenance or detoxification treatment would not be required to obtain a separate registration for a mobile component,” a summary of the rule states.

“This proposed rule would waive the requirement of a separate registration at each principal place of business or professional practice where controlled substances are dispensed for those NTPs with mobile components that fully comply with the requirements of the proposed rule, once finalized,” the summary continues. “These revisions to the regulations are intended to make maintenance or detoxification treatments more widely available, while ensuring that safeguards are in place to reduce the likelihood of diversion.”

The notice is different from what telehealth and mHealth providers have been waiting for: a rule that would ease federal restrictions on the prescription of scheduled drugs via telemedicine, and one that federal officials had been expected to unveil. It even prompted Virginia Sen. Mark Warner to issue a press release congratulating the DEA on making that move.

“The opioid and addiction epidemic has had a devastating impact on communities in Virginia and across the country,” Warner, who had sent a letter to the DEA in January, said in a press release that has since been deleted. “We need to use every tool at our disposal to ensure that individuals struggling with addiction can access the treatment they need, and telehealth is an important part of that. I am pleased the DEA has finally issued proposed rulemaking that will improve telehealth access for these patients and I hope they will work quickly to finalize this rulemaking once stakeholders have had an opportunity to weigh in.”

With the Special Registration for Telemedicine Act of 2018, which was part of the SUPPORT for Patients and Communities Act signed into law by President Donald Trump in late 2018, the DEA had until October 24, 2019 to set the ground rules for providers with a special registration to prescribe controlled substances.

That deadline passed without action. In November, the Justice Department announced plans to issue a proposed rule to create that registration process. But nothing has happened since then, and the DEA and other federal agencies have refused to give any updates.

Last month’s ruling leaves healthcare providers looking for more leeway in treating substance abuse issues both pleased and disappointed. It’s a step in the right direction for programs using digital health tools, but not the leap forward that so many have been anticipating.

Source: https://mhealthintelligence.com/news/dea-proposes-new-mhealth-rule-for-substance-abuse-treatment

Empower Clinics $CBDT.ca Announces Advancement of Joint Venture with Heritage Cannabis in the United States $WEED.ca $CGC $ACB $APH $CRON.ca $HEXO.ca $OGI.ca

Posted by AGORACOM-JC at 8:24 AM on Thursday, March 5th, 2020
  • Announced the advancement of its previously announced Joint Venture Partnership with Heritage Cannabis Holdings Corp. (CSE: CANN), based in Sandy, Oregon, USA.
  • Now advancing the JV with the order and installation of extraction and post-production equipment units at Empower’s existing licenced hemp processing facility in Sandy, Oregon,
  • Will immediately begin performing hemp-based product manufacturing for proprietary formulations, tolling services, and third-party white labelling services for other distributors throughout the United States

VANCOUVER, BC / March 5, 2020 / EMPOWER CLINICS INC. (CSE:CBDT) (OTC:EPWCF) (Frankfurt 8EC) (“Empower” or the “Company“), a vertically integrated and growth-oriented life sciences company is pleased to announce the advancement of its previously announced Joint Venture Partnership (“JV”) with Heritage Cannabis Holdings Corp. (CSE: CANN) (“Heritage”), based in Sandy, Oregon, USA.

In September 2019, Empower announced it had entered into a Letter of Intent (“LOI”) to form a 50/50 ownership JV with Heritage for the extraction of hemp for CBD oil production, and formulated CBD products. The JV is equally funded by both parties and since formation CDN$250,000 has been provided to the JV.

Heritage and Empower are now advancing the JV with the order and installation of extraction and post-production equipment units at Empower’s existing licenced hemp processing facility in Sandy, Oregon, in order to immediately begin performing hemp-based product manufacturing for proprietary formulations, tolling services, and third-party white labelling services for other distributors throughout the United States.

The proprietary branded products will be distributed through Empower’s corporately owned physician staffed health clinics in Oregon and Arizona, online at www.sunvalleyhealth.com and in upcoming new franchise locations, which currently have access to over 165,000 patients.

Additionally, related downstream equipment is now being installed including gel cap processing, tincture bottle and vape cartridge filling, as well as labelling, packaging, storage and shipping services, to offer full-service end-to-end products to third parties.

Heritage is providing training and supervision related to the proprietary methods of extraction and oil production that is already being successfully produced in Canada by Heritage.

“Having the backing of an experienced partner with the financial strength of Heritage Cannabis is proving to be so beneficial for the development of our first extraction facility”, said Steven McAuley, Chief Executive Officer of Empower. “Together, we have already identified numerous opportunities to bring new orders to the JV facility, ensuring we leverage the capacity we are building.”

“We are very pleased to be advancing our U.S. strategy through this mutually beneficial partnership with Empower, which provides Heritage ease of access to the world’s largest cannabis market”, stated Clint Sharples, Chief Executive Officer of Heritage. “The installation of extraction units is the next phase of the JV and another step toward successfully furthering our growth strategies.”

ABOUT EMPOWER

Empower is a vertically-integrated health & wellness brand with it’s first hemp-derived CBD extraction facility under development, the Company produces its proprietary line of cannabidiol (CBD) based products and distributes products through company owned and franchised clinics, with wholesale partnerships, online channels and with new retail opportunities nationwide in the U.S. The company is a leading multi-state operator of a network of physician-staffed wellness clinics, focused on helping patients improve and protect their health, through innovative physician recommended treatment options. The company has commenced activity on how to connect its significant data, to the potential of the efficacy of alternative treatment options related to hemp-derived cannabidiol (CBD) therapies.

About Heritage Cannabis Holdings Corp.

The Company is focused on becoming a vertically integrated cannabis provider that currently has two Health Canada approved licenced producers, through its subsidiaries Voyage Cannabis Corp. and CannaCure Corp. both regulated under the Cannabis Act Regulations. Working under these two licences, Heritage has two additional subsidiaries, Purefarma Solutions, which provides extraction services, and a Medical Services Division which is focused on cannabis based medical solutions. Heritage as the parent company, is focused on providing the resources for its subsidiaries to advance their products or services to compete both domestically and internationally.

ON BEHALF OF THE BOARD OF DIRECTORS:

Steven McAuley
Chief Executive Officer

CONTACTS:

Investors: Steven McAuley
CEO
[email protected]
604-789-2146

Investors: Dustin Klein
SVP, Business Development
[email protected]
720-352-1398

For French inquiries: Remy Scalabrini, Maricom Inc., E: [email protected], T: (888) 585-MARI

DISCLAIMER FOR FORWARD-LOOKING STATEMENTS

This news release contains certain “forward-looking statements” or “forward-looking information” (collectively “forward looking statements”) within the meaning of applicable Canadian securities laws. All statements, other than statements of historical fact, are forward-looking statements and are based on expectations, estimates and projections as at the date of this news release.Forward-looking statements can frequently be identified by words such as “plans”, “continues”, “expects”, “projects”, “intends”, “believes”, “anticipates”, “estimates”, “may”, “will”, “potential”, “proposed” and other similar words, or information that certain events or conditions “may” or “will” occur. Forward-looking statements in this news release include statements regarding; the Company’s intention to open a hemp-based CBD extraction facility, the expected benefits to the Company and its shareholders as a result of the proposed acquisitions and partnerships; the effectiveness of the extraction technology; the expected benefits for Empower’s patient base and customers; the benefits of CBD based products; the effect of the approval of the Farm Bill; the growth of the Company’s patient list and that the Company will be positioned to be a market-leading service provider for complex patient requirements in 2019 and beyond. Such statements are only projections, are based on assumptions known to management at this time, and are subject to risks and uncertainties that may cause actual results, performance or developments to differ materially from those contained in the forward-looking statements, including; that the Company may not open a hemp-based CBD extraction facility; that legislative changes may have an adverse effect on the Company’s business and product development; that the Company may not be able to obtain adequate financing to pursue its business plan; general business, economic, competitive, political and social uncertainties; failure to obtain any necessary approvals in connection with the proposed acquisitions and partnerships; and other factors beyond the Company’s control. No assurance can be given that any of the events anticipated by the forward-looking statements will occur or, if they do occur, what benefits the Company will obtain from them. Readers are cautioned not to place undue reliance on the forward-looking statements in this release, which are qualified in their entirety by these cautionary statements. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements in this release, whether as a result of new information, future events or otherwise, except as expressly required by applicable laws.

PyroGenesis $PYR.ca Successfully Completes all Torch Tests for RISE Energy Technology Center AB LMT $RTN $NOC $UTX $HPQ.ca $DDD.ca $SSYS $PRLB

Posted by AGORACOM-JC at 3:04 PM on Wednesday, March 4th, 2020
  • Further to its previous press release dated November 4th, 2019, Company has completed all torch tests successfully, and has received final payment from RISE Energy Technology Center AB
  • As a result of this success, PyroGenesis has received numerous requests for proposals from potential clients in the field, and recently signed a small order from a multi-billion-dollar international producer of iron pellets 

MONTREAL, March 04, 2020 — PyroGenesis Canada Inc. (http://pyrogenesis.com) (TSX-V: PYR) (OTCQB: PYRNF) (FRA: 8PY), a high-tech company, (the “Company”, the “Corporation” or “PyroGenesis”) that designs, develops, manufactures and commercializes plasma atomized metal powder, plasma waste-to-energy systems and plasma torch products, announced today that, further to its previous press release dated November 4th, 2019, the Company has completed all torch tests successfully, and has received final payment from RISE Energy Technology Center AB (the “Client”).

This contract, originally announced in January of last year, is for a 900-kW plasma torch system which was won in a competitive bid process.

PyroGenesis’ 900-kW plasma torch is used to replace fossil fuel burners in the iron ore induration (pelletization) process. Pelletization is the process in which iron ore is concentrated before shipment, thus significantly reducing the cost of transportation. In conventional technology, the process heat is provided by fuel oil or natural gas burners. The combustion, in the burners, of fossil fuels results in the production of greenhouse gases, mainly CO2. Plasma torches, by the fact that they can convert renewable electricity to heat offer an environmentally attractive alternative to fossil fuel burners.

Following the success of the SAT (Site Acceptance Test) of the high-power plasma torch at the Client’s facility in Sweden, a series of additional torch tests were performed at the client’s site.  As announced, these tests have concluded successfully, and discussions are now taking place for follow on work and additional torch orders.

According to management, a typical pellet plant producing 10 million metric tonnes of pellets annually emits approximately one million metric tonnes of CO21. The total world pellet production of 400 million metric tonnes of pellets represents a potential market for torch sales in excess of $10B worldwide. The world pellet industry generates about 40 million metric tonnes of CO2 every year. The use of plasma torches running off a clean electrical grid would reduce these emissions significantly. For reference, 40 million tonnes of CO2 represent the combined yearly emissions of 8.7 million US passenger vehicles2.

As a result of this success, PyroGenesis has received numerous requests for proposals from potential clients in the field, and recently signed a small order from a multi-billion-dollar international producer of iron pellets.  This order is to model and evaluate the performance of PyroGenesis’ torch in an existing industrial furnace. If successful, this would potentially lead to a multi-torch order aimed at replacing burners in their industrial pelletizing plant. An iron pelletizing furnace typically uses dozens of high-power burners (typically between 1-5 MW). 

“Our success with RISE has demonstrated to the industrial manufacturing sector that our Plasma Torches represent an opportunity to significantly cut GHG emissions through a simple bolt-on replacement of their current fossil fuel burners,” said Mr. P. Peter Pascali, President and CEO of PyroGenesis. “Given how compelling our torch offering is, particularly in light of the environmental pressure the industry is under (only recently a new trend has emerged where financial institutions are tying credit facilities and debt issuances to carbon reduction targets for multi-national industrial and mining conglomerates) we expect the demand for our torches to grow exponentially.”

1 M. Huerta, J. Bolen, M. Okrutny, I. Cameron and K. O’Leary, “Guidelines for Selecting Pellet Plant Technology”, Iron Ore Conference 2015 Proceedings, Perth, WA, July 13-15, 2015

2 https://www.epa.gov/greenvehicles/greenhouse-gas-emissions-typical-passenger-vehicle

About PyroGenesis Canada Inc.

PyroGenesis Canada Inc., a high-tech company, is the world leader in the design, development, manufacture and commercialization of advanced plasma processes and products. We provide engineering and manufacturing expertise, cutting-edge contract research, as well as turnkey process equipment packages to the defense, metallurgical, mining, advanced materials (including 3D printing), oil & gas, and environmental industries. With a team of experienced engineers, scientists and technicians working out of our Montreal office and our 3,800 m2 manufacturing facility, PyroGenesis maintains its competitive advantage by remaining at the forefront of technology development and commercialization. Our core competencies allow PyroGenesis to lead the way in providing innovative plasma torches, plasma waste processes, high-temperature metallurgical processes, and engineering services to the global marketplace. Our operations are ISO 9001:2015 and AS9100D certified, and have been since 1997. PyroGenesis is a publicly-traded Canadian Corporation on the TSX Venture Exchange (Ticker Symbol: PYR) and on the OTCQB Marketplace. For more information, please visit www.pyrogenesis.com.

This press release contains certain forward-looking statements, including, without limitation, statements containing the words “may”, “plan”, “will”, “estimate”, “continue”, “anticipate”, “intend”, “expect”, “in the process” and other similar expressions which constitute “forward- looking information” within the meaning of applicable securities laws. Forward-looking statements reflect the Corporation’s current expectation and assumptions and are subject to a number of risks and uncertainties that could cause actual results to differ materially from those anticipated. These forward-looking statements involve risks and uncertainties including, but not limited to, our expectations regarding the acceptance of our products by the market, our strategy to develop new products and enhance the capabilities of existing products, our strategy with respect to research and development, the impact of competitive products and pricing, new product development, and uncertainties related to the regulatory approval process. Such statements reflect the current views of the Corporation with respect to future events and are subject to certain risks and uncertainties and other risks detailed from time-to-time in the Corporation’s ongoing filings with the securities regulatory authorities, which filings can be found at www.sedar.com, or at www.otcmarkets.com. Actual results, events, and performance may differ materially. Readers are cautioned not to place undue reliance on these forward-looking statements. The Corporation undertakes no obligation to publicly update or revise any forward- looking statements either as a result of new information, future events or otherwise, except as required by applicable securities laws. Neither the TSX Venture Exchange, its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) nor the OTCQB accepts responsibility for the adequacy or accuracy of this press release.

SOURCE PyroGenesis Canada Inc.

For further information please contact:

Rodayna Kafal, Vice President Investors Relations and Strategic Business Development
Phone: (514) 937-0002, E-mail: [email protected]